Nasdaq

Ceribell Wins FDA Clearance For Neonatal Use Of Clarity Algorithm

(RTTNews) - CeriBell, Inc. (CBLL) announces that the U.S. FDA has granted 510(k) clearance for its next-generation Clarity algorithm to detect electrographic seizures in preterm neonates through ...
Nasdaq

FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in ...

Powered by Clarity, the Ceribell System will enable rapid, bedside detection, diagnosis and treatment of non-convulsive seizures in children experiencing neurological emergencies SUNNYVALE, Calif., ...
Healio

Ketamine effective treatment for neonatal, pediatric epilepsy

Treatment with ketamine significantly improved seizure occurrence related to refractory status epilepticus in both neonates and children, according to results of a study published in Neurology. “Many ...
Investing

Ceribell receives FDA clearance for neonatal seizure detection

SUNNYVALE, Calif. - CeriBell, Inc. (NASDAQ:CBLL) announced Monday that the U.S. Food and Drug Administration has granted 510(k) clearance for its next-generation Clarity algorithm to detect ...
Investing

CeriBell stock rises after FDA clearance for neonatal seizure detection

Investing.com -- CeriBell Inc (NASDAQ:CBLL) stock rose 2.2% in premarket trading Monday after the medical technology company announced FDA clearance for its AI-powered seizure detection algorithm for ...
EurekAlert!

CHOP researchers develop first-of-its-kind prediction model for newborn seizures

Philadelphia, March 22, 2023 – Researchers from the Neuroscience Center at Children’s Hospital of Philadelphia (CHOP) have developed a prediction model that determines which newborn babies are likely ...